Trademark Search in Canada

MIPLYM

View On IC.GC.CA

REGISTERED

on 10 Aug 2022

Last Applicant/ Owned by

OTSUKA PHARMACEUTICAL CO. LTD.

2-9 Kanda-Tsukasamachi,Chiyoda-kuTokyo 101-8535

Serial Number

2014169 filed on 12^th Dec 2019

Registration Number

TMA1137393 registered on 10^th Aug 2022

Registration expiry Date

12^th Dec 2029

Correspondent Address

SMART & BIGGAR LP

SUITE 1000, 55 METCALFE STREETP.O. BOX 2999, STATION DOTTAWA

ONTARIO

K1P5Y6

MIPLYM

Trademark usage description

pharmaceutical preparations for the prevention and treatment of cancer; biological preparations for medical purposes for the prevention and treatment Read More

Classification Information

Class [005]
Pharmaceutical preparations for the prevention and treatment of cancer; biological preparations for medical purposes for the prevention and treatment of cancer; regenerative preparations for medical purposes for the prevention and treatment of cancer; cell preparations, namely, human cells for medical purposes for the treatment of cancer; stem cells for medical purposes; cells for medical use for the prevention and treatment of cancer

Classification kind code

Class [040]
Custom processing of human cells for others; custom processing of therapeutic cells for others; custom cultivation of human cells as medical materials for others; custom cultivation of human cells for others for medical purposes; custom manufacture of pharmaceuticals; custom manufacture of biopharmaceuticals.

Classification kind code

Class [042]
Scientific and medical research and development relating to the isolation and cultivation of human tissues and cells; scientific services relating to the isolation and cultivation of human tissues and cells; analysis of human tissues and cells for medical research; cultivation of human cells; cultivation of cells for transplant taken from patients

Classification kind code

Class [044]
Medical services in the field of chimeric antigen receptor (CAR) T-cell therapy for the prevention and treatment of cancer; provision of medical information in the field of chimeric antigen receptor (CAR) T-cell therapy for the prevention and treatment of cancer; medical services relating to the removal, treatment and processing of human blood, human cells and stem cells; medical therapy services in the field of chimeric antigen receptor (CAR) T-cell therapy for the prevention and treatment of cancer; medical treatment services in the field of chimeric antigen receptor (CAR) T-cell therapy for the prevention and treatment of cancer; medical treatment services with cell preparations in the field of chimeric antigen receptor (CAR) T-cell therapy for the prevention and treatment of cancer; medical treatment services with processed and cultivated cells in the field of chimeric antigen receptor (CAR) T-cell therapy for the prevention and treatment of cancer; human tissue and cell bank services; analysis of human tissues and cells for medical treatment; collection, testing and preservation of human blood, human cells and stem cells

Classification kind code

Mark Details

Serial Number

2014169

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 48 on 6^th Dec 2021	Agent Changed
Submitted for opposition 22 on 5^th Jul 2021	Search Recorded
Submitted for opposition 20 on 5^th Jul 2021	Examiner's First Report
Submitted for opposition 223 on 5^th Jul 2021	Total Provisional Refusal
Submitted for opposition 256 on 28^th Dec 2020	Notification of Possible Opposition Sent
Submitted for opposition 257 on 27^th Feb 2020	Designation Notification - Madrid Protocol
Submitted for opposition 31 on 26^th Feb 2020	Formalized
Submitted for opposition 1 on 26^th Feb 2020	Created
Submitted for opposition 228 on 12^th Dec 2019	International Registration
Submitted for opposition 30 on 12^th Dec 2019	Filed